Edilytics
Austin Walters is the Founder & Managing Partner at SpringTide Ventures, a venture capital firm focused on healthcare companies. Austin is also the Co-Founder and CRO at Edilytics, which specializes in precision algorithms for analyzing genome editing data. Additionally, Austin serves as an Investor & Board Director at Prolucent Health and Vigor, as well as a Seed Investor at Great Expectations. With a background in management consulting and a strong focus on disruptive innovation, Austin brings a diverse skill set to the companies Austin invests in and supports.
This person is not in any teams
Edilytics
Genome editing is transforming the way biological science is done and accelerating medical breakthroughs. CRISPR technology has reduced the barrier to creating predictable changes to DNA, encouraging scientific investigators and entrepreneurs to adopt and use the technology. However, robust and rigorous computational tools are critical for the correct analysis, interpretation and verification of biological results. We build precision algorithms for analyzing genome editing experimental data, and provide customized computational support to address critical questions in the processing of next-generation sequencing data. Please get in touch with us to get more information or to start a collaboration.